Phoenix Biotech Acquisiti... (PBAX)
NASDAQ: PBAX
· Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM
Phoenix Biotech Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254.83K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254.83K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.95M | -14.49M | -4.4M | -5.15M | -429.8K | -1.54M | -590.27K | 378K | 144.97K | -111.57K | -378B | -332.03K | n/a |
Interest Income | n/a | -380.58K | n/a | n/a | 121.52K | 150.5K | 108.56K | n/a | 320.48K | 37.11K | n/a | n/a | n/a |
Pretax Income | -5.45M | -8.91M | -4.23M | -2.45M | -308.28K | -1.39M | -481.71K | 276.02K | 144.97K | -111.57K | -378K | -332.42K | n/a |
Net Income | -5.45M | -8.94M | -4.23M | -2.45M | -334.03K | -1.44M | -373.16K | -262.68K | 84.5K | -339.47K | 378B | -315.55K | n/a |
Selling & General & Admin | 2.04M | 6.6M | 2.63M | 2.43M | 430.9K | 1.52M | 566.57K | 1.37M | 786.68K | 326.58K | 354.78K | 251.71K | n/a |
Research & Development | 2.91M | 7.08M | 1.77M | 2.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | -2.1K | n/a | n/a | n/a | -22.7K | 23.7K | -85.95K | 50K | 50K | 50K | n/a | n/a |
Operating Expenses | 4.95M | 13.68M | 4.4M | 5.15M | 429.8K | 1.54M | 590.27K | 1.29M | 836.68K | 376.58K | 404.78K | 332.03K | n/a |
Interest Expense | 850.00 | n/a | n/a | -16.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 13.68M | n/a | n/a | 429.8K | 1.54M | 590.27K | 1.29M | 836.68K | 376.58K | 404.78K | 332.03K | n/a |
Income Tax Expense | n/a | 38.15K | n/a | n/a | 25.75K | 44.66K | -108.56K | 538.7K | 60.46K | 227.9K | -378B | -16.87K | n/a |
Shares Outstanding (Basic) | 49.68M | 49.68M | 49.68M | 48.6M | 56.99M | 60.93M | 60.93M | 63.08M | 68.94M | 68.94M | 68.94M | 68.94M | 68.94M |
Shares Outstanding (Diluted) | 49.68M | 49.68M | 49.68M | 48.6M | 56.99M | 60.93M | 60.93M | 63.08M | 68.94M | 68.94M | 68.94M | 68.94M | 68.94M |
EPS (Basic) | -0.11 | -0.18 | -0.09 | -0.05 | -0.01 | -0.02 | -0.01 | -0.00 | 0.00 | -0.00 | 5.48K | -0.00 | n/a |
EPS (Diluted) | -0.11 | -0.18 | -0.09 | -0.05 | -0.01 | -0.02 | -0.01 | -0.00 | 0.00 | -0.00 | 5.48K | -0.00 | n/a |
EBITDA | -4.95M | -8.21M | -4.4M | -5.15M | -429.8K | -1.54M | -590.27K | -3.21M | -1.5M | -604.48K | -431.56K | -332.03K | n/a |
EBIT | n/a | n/a | n/a | n/a | -429.8K | n/a | n/a | 378K | 144.97K | -111.57K | -378B | n/a | n/a |
Depreciation & Amortization | n/a | 695.93K | n/a | n/a | -859.6K | 122.08K | 41.58K | -3.59M | -1.64M | -492.91K | 378B | 71.39K | 54K |